To conclude, here we show that BLT1-antagonism does not affect plaque size and morphology during advanced stages of atherosclerosis, which suggests that LTB4 is not involved in the progression of advanced atherosclerotic lesions. The gene discussed is LTB4R; the disease is atherosclerosis.